Cavitation Technologies, Inc.
No SEC Form 4 filings for $CVAT in the last 30 days.
See all $CVAT insider activity →Cavitation Technologies (CVAT) signed agreements with BrightFlixx Finance for $42M cash tender offers, including $35M for CVAT and $7M for Alchemy. The offers replace prior agreements and are pending regulatory filings and conditions.
Cavitation Technologies reported FY 2026 revenue of $3K, down 98.5% YoY, and a net loss of $1.4M, widened from $113K. The decline was due to a shift from product sales to rental and demo income. The company assigned vegetable oil refining patents to Desmet, retaining exclusive licenses for other markets. Cash constraints led to reduced R&D and reliance on partners for commercialization.
Cavitation Technologies, Inc. (CVAT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 Cavitation Technologies, Inc. Executes Definitive Purchase Agreement with European Guarantee Services S.à.r.l CHATSWORTH, CA – August 17, 2026 (GLOBE NEWSWIRE) – Cavitation Technologies, Inc. (OTCQB: CVAT) ("CVAT" or the "Company"), a leading provider of sustainable
Over the past 7 days, AlphAI's AI scored 3 news stories mentioning CVAT (Cavitation Technologies, Inc.). Coverage has been balanced: 1 bullish, 1 neutral, and 1 bearish.
Recent CVAT coverage spans corporate actions and earnings.
Definitive tender-offer financing terms are a near-term catalyst that can tighten spreads and increase buyback/tender arbitrage interest, but execution depends on filings and conditions.
The drastic revenue decline and widening loss suggest severe earnings pressure.
Potential premium to current market price may trigger share price surge if shareholders tender.
AlphAI scores every news story that mentions CVAT with an AI model for sentiment and relevance, and aggregates insider trades from Cavitation Technologies, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Cavitation Technologies (CVAT) signed agreements with BrightFlixx Finance for $42M cash tender offers, including $35M for CVAT and $7M for Alchemy. The offers replace prior agreements and are pending regulatory filings and conditions.
3 min readCavitation Technologies reported FY 2026 revenue of $3K, down 98.5% YoY, and a net loss of $1.4M, widened from $113K. The decline was due to a shift from product sales to rental and demo income. The company assigned vegetable oil refining patents to Desmet, retaining exclusive licenses for other markets. Cash constraints led to reduced R&D and reliance on partners for commercialization.
2 min readCavitation Technologies, Inc. (CVAT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 Cavitation Technologies, Inc. Executes Definitive Purchase Agreement with European Guarantee Services S.à.r.l CHATSWORTH, CA – August 17, 2026 (GLOBE NEWSWIRE) – Cavitation Technologies, Inc. (OTCQB: CVAT) ("CVAT" or the "Company"), a leading provider of sustainable
1 min read
